NCT05840068View on ClinicalTrials.gov

IGF Level in Breast Cancer Patients Treated With Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Breast Cancer Female
Interventions
DRUG

MetFORMIN 500 Mg Oral Tablet

MetFORMIN 500 Mg Oral Tablet

DRUG

Chemotherapy

The standard chemotherapy protocol developed by the South Egypt Cancer Institute (SECI).

Trial Locations (1)

62514

Marian S. Boshra, Banī Suwayf

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT05840068 - IGF Level in Breast Cancer Patients Treated With Metformin | Biotech Hunter | Biotech Hunter